Press Releases Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Market Closed - OTC Markets Other stock markets 09:30:18 2024-07-09 am EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	-93.33%

May. 07	IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.	CI
May. 06	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K	Mar. 06	PU
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates	Dec. 18	AQ
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4	Nov. 13	AQ
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board	Nov. 03	AQ
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)	23-10-05	AQ
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023	23-10-04	AQ
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer	23-06-27	AQ
Theralink Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University	23-04-04	AQ
Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University	23-04-03	PR
Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone	23-02-23	PR
THERALINK TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23-02-21	AQ
THERALINK TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	23-02-01	AQ
Theralink's Exclusive Licensed RPPA Technology for Commercial Laboratory Testing to Assist the White House Cancer Moonshot Initiative	23-01-17	PR
Theralink® Technologies Appoints Michael Vallone as Senior Director of Commercialization	23-01-09	PR
THERALINK TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-12-29	AQ
THERALINK TECHNOLOGIES, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-12-09	AQ
THERALINK TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-01	AQ
Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium	22-12-01	PR
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares	22-11-29	PR
Theralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment	22-11-14	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Press Releases

Filters